A review of the consequences of additional private drugs for NHS care

LETTER FROM PROFESSOR MIKE RICHARDS: A REVIEW OF THE CONSEQUENCES OF ADDITIONAL PRIVATE DRUGS FOR NHS CARE

July 2008

“This letter from Professor Mike Richards, National Clinical Director, highlights the policy review he is undertaking relating to patients who choose to pay privately for drugs not funded by the NHS.”